research Eflúvio telogeno pós-COVID
COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.
Search
for
Sort by
Research
180-210 / 1000+ results 
research Expert consensus on the management of telogen effluvium in India
Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.
research A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research Time of onset and duration of post-COVID-19 acute telogen effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
COVID-19 has increased hair loss, but many patients see regrowth within months.
research Localized Telogen Effluvium after Face Lift Surgery
A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.
research Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications
ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.
research Chronic telogen effluvium in a man
The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.
research Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single‐Center Experience
Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.
research Suprabulbar Thinning of Hair in Telogen Effluvium
Hair is thinner near the scalp in acute hair shedding conditions.
research Reduced Ferritin, Folate and Vitamin B12 Levels in Female Patients Diagnosed With Telogen Effluvium
Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.
research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
research SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.
research A Severe Case of Diffuse Telogen Effluvium Status Post Endoscopic Repair of Functional Brow Ptosis
A patient's hair loss after a browlift surgery improved on its own over 8 months.
research Localized Donor Area Acute Telogen Effluvium following Follicular Unit Extraction: Key Trichoscopic Findings
Hair loss can occur in the area where hair was taken for a transplant.
research Distinguishing Androgenetic Alopecia From Chronic Telogen Effluvium When Associated in the Same Patient: A Simple Noninvasive Method
research A Canadian Algorithm on the Management of Telogen Effluvium.
A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.
research Covid induced telogen effluvium (CITE): An insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research COVID ‐19 induced telogen effluvium
COVID-19 may cause temporary hair loss in some people.
research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
research Postpartum Telogen Effluvium Unmasking Traction Alopecia
Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.
research Chronic telogen effluvium is due to a reduction in the variance of anagen duration
Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.
research Alopecias Due to Drugs and Other Skin and Systemic Disorders
Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.
research Poster 150 Rehabilitating the Journal Club: A Review of Journal Clubs in Physical Medicine and Rehabilitation
The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.
research Telogen effluvium associated with COVID‐19 infection
COVID-19 may cause hair loss due to infection stress or treatments.
research Telogen Effluvium as a complication of scalp reconstruction with tissue expander: a case report.
A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.
research Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia
Hair loss causes stress and affects mental health; treatment and support needed.
research Telogen effluvium in SARS‐CoV ‐2 infection: Histological aspects
COVID-19 can cause a temporary hair loss condition.
research Tratamento do Eflúvio Telógeno Pós-Covid 19
Topical Minoxidil is effective for hair loss after COVID-19.
research CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA
COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.